← Back to Clinical Trials
Recruiting NCT06580652

NCT06580652 Respiratory Parameters Using Advanced Airways During In-hospital Cardiac Arrest

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06580652
Status Recruiting
Phase
Sponsor Royal United Hospitals Bath NHS Foundation Trust
Condition Cardiac Arrest
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-08-28
Primary Completion 2026-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-08-28 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators aim to investigate the real life volumes of air delivered to the lungs when rescuers deliver these breaths by hand as part of resuscitation attempts during cardiac arrest. The study will compare the volumes achieved using different devices which are routinely used to provided an airway during routine cardiac arrest care. Volumes will be measured using a small non intrusive device which sits in the airway circuit and measures flow of air in real time. The patients chosen for this study will be those already recruited to an ongoing trial (AIRWAYS-3) assessing the outcomes for patients suffering in hospital cardiac arrest based on airway device used.

Eligibility Criteria

Inclusion Criteria: * As per AIRWAYS-3 trial: * In-hospital cardiac arrest, attended by the hospital cardiac arrest team in response to a cardiac arrest call (2222 or equivalent), and when a clinician permitted to undertake both tracheal intubation and supraglottic airway placement (so that either intervention can be delivered) is present * Undergoing resuscitation and requiring advanced airway management in the opinion of the trained clinician responsible for randomisation Exclusion Criteria: * As per AIRWAYS-3 trial * Patients who have a cardiac arrest outside hospital and who are transported to the hospital in ongoing cardiac arrest * People who are not a hospital inpatient (e.g. visitor, relative, staff or outpatient) * Patients who are already tracheally intubated at the time of eligibility assessment * Patients known to be pregnant * Patients with a functioning tracheostomy

Contact & Investigator

Central Contact

James Penketh

✉ jpenketh@nhs.net

📞 07973504245

Principal Investigator

Kelly Spencer

STUDY CHAIR

Royal United Hosptial Bath

Frequently Asked Questions

Who can join the NCT06580652 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06580652 currently recruiting?

Yes, NCT06580652 is actively recruiting participants. Contact the research team at jpenketh@nhs.net for enrollment information.

Where is the NCT06580652 trial being conducted?

This trial is being conducted at Bath, United Kingdom.

Who is sponsoring the NCT06580652 clinical trial?

NCT06580652 is sponsored by Royal United Hospitals Bath NHS Foundation Trust. The principal investigator is Kelly Spencer at Royal United Hosptial Bath. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology